GO:0005890 sodium:potassium-exchanging ATPase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005890 describes the sodium:potassium-exchanging ATPase complex, a tetrameric ion pump composed of two alpha and two beta subunits.
• The complex hydrolyzes ATP to transport three Na+ ions out and two K+ ions into the cell, maintaining electrochemical gradients essential for excitability and volume regulation.
• The alpha subunit contains the catalytic site and spans the membrane, while the beta subunit is heavily glycosylated and faces the extracellular space.
• Dysfunction of the sodium pump is linked to cardiovascular disease, cancer, and neurological disorders, making it a major therapeutic target.
• Cardiac glycosides such as digoxin inhibit the pump and have been used for decades in heart failure and arrhythmia.
• CRISPR-based knockout, knock-in, and point-mutation models are powerful tools to dissect subunit-specific functions and drug responses.
Description
The sodium:potassium-exchanging ATPase complex (GO:0005890), also known as the sodium pump, is a fundamental membrane protein complex responsible for maintaining the electrochemical gradients of sodium and potassium across the plasma membrane. It belongs to the P-type ATPase family and is essential for cellular homeostasis, volume regulation, and electrical excitability in virtually all animal cells. The complex is a tetramer of two alpha and two beta subunits, with the alpha subunit carrying the catalytic ATPase site and the beta subunit being heavily glycosylated. Because of its central role in physiology, the sodium pump is a target for drugs such as cardiac glycosides and is implicated in a wide range of diseases including heart failure, hypertension, and cancer. Understanding its structure, regulation, and interacting partners is therefore of high priority for both basic and translational research. This article provides a comprehensive overview of GO:0005890, covering its definition, subunit composition, molecular mechanism, disease relevance, and modern research methods including CRISPR-based models.
sodium:potassium-exchanging ATPase complex At A Glance
| GO ID | GO:0005890 |
|---|---|
| GO term | sodium:potassium-exchanging ATPase complex |
| Ontology | cellular_component |
| Synonym | sodium/potassium-exchanging ATPase complex, sodium pump |
| Major function | ATP-dependent exchange of Na+ and K+ across the plasma membrane |
| Subunit composition | Tetramer of two alpha and two beta subunits |
| Cellular location | Plasma membrane |
| Catalytic subunit | Alpha subunit (contains ATPase active site) |
| Regulatory subunit | Beta subunit (glycosylated, extracellular) |
What Is GO:0005890?
GO:0005890, sodium:potassium-exchanging ATPase complex, is a cellular component term describing a tetrameric protein complex that consists of two large alpha subunits and two smaller beta subunits. The alpha subunits bear the active site and penetrate the membrane, while the beta subunits carry oligosaccharide groups and face the cell exterior. This complex catalyzes the ATP-dependent exchange of sodium and potassium ions across the membrane, a process critical for maintaining resting membrane potential and cellular ion gradients.
Why Is sodium:potassium-exchanging ATPase complex Important in Cell Biology?
The sodium:potassium-exchanging ATPase complex is vital for maintaining the resting membrane potential, regulating cell volume, and providing the driving force for secondary active transport of nutrients and ions. It consumes a large fraction of cellular ATP and is essential for nerve impulse transmission, muscle contraction, and kidney function. Its dysfunction or dysregulation is associated with cardiovascular diseases such as heart failure and hypertension, as well as cancer and neurological disorders. Moreover, the complex is the receptor for cardiac glycosides, a class of drugs used to treat heart failure and atrial arrhythmias. Because of its central physiological importance, the sodium pump is a major focus of research in cell biology, pharmacology, and medicine.
• Maintains resting membrane potential and electrical excitability in neurons and muscle cells.
• Regulates cell volume and intracellular ion homeostasis.
• Provides the electrochemical gradient for secondary active transport of glucose, amino acids, and other solutes.
• Target of cardiac glycosides (e.g., digoxin) used in heart failure and arrhythmia.
• Implicated in cancer cell proliferation and survival, with Na+/K+ ATPase inhibitors showing anticancer potential.
• Hormonal regulation (e.g., by insulin, thyroid hormone, aldosterone) adjusts pump activity to metabolic demand.
• Serves as a signal transducer through protein-protein interactions, influencing cell growth and differentiation.
• Mutations in ATP1A2 and ATP1A3 cause neurological disorders such as familial hemiplegic migraine and alternating hemiplegia of childhood.
• Evolutionary conservation from early metazoans highlights its fundamental role in animal physiology.
• Provides a model system for studying P-type ATPase mechanism and ion transport.
What Happens During sodium:potassium-exchanging ATPase complex?
Ion Binding and ATP Hydrolysis
In simple terms: The pump uses energy from ATP to move sodium out and potassium in.
The catalytic alpha subunit binds three intracellular Na+ ions and ATP. ATP hydrolysis phosphorylates the pump, causing a conformational change that occludes Na+ and releases them to the extracellular side. This step is the primary energy-consuming event and is tightly coupled to ion transport.
Conformational Cycling (E1-E2)
In simple terms: The pump changes shape to alternately expose ion binding sites to the inside and outside of the cell.
The sodium pump cycles between E1 and E2 conformational states. In E1, the pump has high affinity for Na+ and faces the cytoplasm; in E2, it has high affinity for K+ and faces the extracellular space. Phosphorylation and dephosphorylation drive these transitions, enabling the counter-transport of Na+ and K+.
Potassium Binding and Dephosphorylation
In simple terms: Potassium from outside binds to the pump, triggering release of phosphate and resetting the pump.
After Na+ is released, two extracellular K+ ions bind to the E2 state. This binding stimulates dephosphorylation, returning the pump to the E1 state and releasing K+ into the cytoplasm. The cycle is then ready for another round of ATP hydrolysis and ion transport.
Regulation by Hormones and Second Messengers
In simple terms: Hormones and signaling molecules can turn the pump up or down.
The sodium pump is regulated by hormones such as insulin, aldosterone, and thyroid hormone, which can alter its activity, trafficking, or expression. Protein kinases (e.g., PKA, PKC) phosphorylate the alpha subunit and modulate pump function. These regulatory mechanisms allow the pump to adapt to changing physiological demands.
Key Genes Involved in GO:0005890 sodium:potassium-exchanging ATPase complex
The sodium:potassium-exchanging ATPase complex is composed of multiple subunit isoforms encoded by distinct genes, with additional regulatory proteins modulating its function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP1A1 | Alpha-1 subunit; ubiquitous Na+/K+ ATPase | Major isoform in most tissues; target of cardiac glycosides; implicated in cancer and hypertension |
| ATP1A2 | Alpha-2 subunit; expressed in muscle, heart, brain | Mutations cause familial hemiplegic migraine and other neurological disorders |
| ATP1A3 | Alpha-3 subunit; neuronal | Mutations linked to alternating hemiplegia of childhood and dystonia |
| ATP1A4 | Alpha-4 subunit; testis-specific | Role in sperm motility; potential contraceptive target |
| ATP1B1 | Beta-1 subunit; ubiquitous | Chaperone-like function; mutations cause neurological and renal disorders |
| ATP1B2 | Beta-2 subunit; neural | Important for neuronal function; implicated in neurodegenerative diseases |
| ATP1B3 | Beta-3 subunit; widespread | May regulate pump activity in cancer; potential biomarker |
| ATP1B4 | Beta-4 subunit; muscle and brain | Unusual isoform with role in development; less studied |
| FXYD1 | Phospholemman; regulatory subunit | Modulates pump activity in heart; target for cardiac research |
| FXYD2 | Gamma subunit; kidney | Regulates pump in kidney; mutations cause hypomagnesemia |
| FXYD3 | Mammary tumor marker | Overexpressed in cancers; potential therapeutic target |
| FXYD4 | Corticosteroid-induced; kidney | Regulates sodium transport in kidney |
| FXYD5 | Dysadherin; cancer-related | Promotes metastasis; interacts with pump |
| FXYD6 | Brain and heart | Modulates pump activity; linked to psychiatric disorders |
| FXYD7 | Brain-specific | Regulates neuronal pump; may affect behavior |
| ATP1A1-AS1 | Antisense RNA | Regulates ATP1A1 expression; potential cancer biomarker |
| SRC | Non-receptor tyrosine kinase | Interacts with pump to mediate signal transduction |
| PIK3CA | Phosphatidylinositol 3-kinase | Part of signaling crosstalk with pump |
How Is sodium:potassium-exchanging ATPase complex Regulated?
The sodium:potassium-exchanging ATPase complex is regulated at multiple levels, including gene expression, subunit assembly, membrane trafficking, and post-translational modifications. Hormones such as insulin, aldosterone, and thyroid hormone modulate pump activity to meet metabolic demands. Protein kinases (e.g., PKA, PKC) phosphorylate the alpha subunit, affecting ion transport and pump trafficking. Additionally, FXYD proteins associate with the pump and alter its kinetic properties in a tissue-specific manner. The pump also participates in signal transduction complexes with Src and other kinases, linking ion transport to cell growth and differentiation.
sodium:potassium-exchanging ATPase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP1A1 | Hypertension, cancer, cardiac glycoside sensitivity | Knockout and point-mutation cell lines; cardiac glycoside resistance assays |
| ATP1A2 | Familial hemiplegic migraine | Knock-in mouse models; neuronal cell lines with patient mutations |
| ATP1A3 | Alternating hemiplegia of childhood | Patient-derived iPSCs; knock-in mice |
| ATP1B1 | Neurological and renal disorders | Knockout zebrafish; kidney epithelial cells |
| FXYD2 | Hypomagnesemia | Knockout mice; renal tubule cell lines |
Cardiovascular Diseases
The sodium pump is critical for cardiac contractility and rhythm. Cardiac glycosides like digoxin inhibit the pump, increasing intracellular Na+ and Ca2+, which strengthens heart contractions. Dysregulation of the pump is implicated in heart failure, hypertension, and arrhythmias. Mutations in ATP1A2 can cause familial hemiplegic migraine, and ATP1A3 mutations lead to alternating hemiplegia of childhood.
Cancer
Na+/K+ ATPase is overexpressed in many cancers and contributes to cell proliferation, migration, and survival. Its inhibition by cardiac glycosides or other compounds has shown anticancer effects in preclinical models. The pump also interacts with signaling pathways such as Src and PI3K, promoting oncogenic phenotypes.
Neurological Disorders
Neuronal isoforms ATP1A2 and ATP1A3 are essential for maintaining ion gradients during synaptic activity. Mutations in these genes cause familial hemiplegic migraine, alternating hemiplegia of childhood, and rapid-onset dystonia-parkinsonism. The pump also plays a role in neurodegenerative conditions such as Alzheimer's disease, where its activity may be altered.
Renal and Metabolic Disorders
In the kidney, the sodium pump drives sodium reabsorption and is regulated by aldosterone. Mutations in FXYD2 cause hypomagnesemia with secondary hypocalcemia. The pump is also involved in salt-sensitive hypertension and diabetic nephropathy.
From sodium:potassium-exchanging ATPase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of ATP1A1? | CRISPR knockout in HeLa or HEK293 cells |
| How does a specific point mutation affect ion transport? | Point-mutation knock-in via CRISPR in cell lines |
| What is the role of the beta subunit glycosylation? | Knock-in of glycosylation-deficient ATP1B1 |
| Where is the pump localized in neurons? | Tagged knock-in of ATP1A3 with fluorescent protein |
| Does overexpression of FXYD5 promote metastasis? | Overexpression of FXYD5 in cancer cell lines |
| Can cardiac glycoside resistance be modeled? | CRISPR knockout of ATP1A1 followed by drug selection |
How to Study the sodium:potassium-exchanging ATPase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Determine essentiality of ATP1A1 in cell lines |
| CRISPR knock-in | Introduction of specific mutations | Model patient mutations in ATP1A2 |
| Fluorescent ion indicators | Intracellular Na+ and K+ levels | Assess pump activity in live cells |
| Patch-clamp electrophysiology | Membrane potential and ion currents | Study neuronal excitability |
| Co-immunoprecipitation | Protein-protein interactions | Identify Src binding to pump |
| Cryo-EM | High-resolution structure | Visualize conformational states |
| Molecular dynamics simulation | Ion movement and drug binding | Predict drug resistance mutations |
| RNA-seq | Gene expression changes | Evaluate compensatory subunit upregulation |
Genetic Knockout and Knock-in Models
CRISPR/Cas9-mediated knockout of ATP1A1 or other subunits can reveal essential functions and compensatory mechanisms. Knock-in of specific mutations (e.g., those found in patients) allows study of disease mechanisms and drug responses.
Ion Flux and Electrophysiology
Measurements of intracellular Na+ and K+ concentrations using fluorescent dyes or ion-selective electrodes can assess pump activity. Patch-clamp electrophysiology in neurons or cardiomyocytes can evaluate the impact of pump mutations on membrane potential and excitability.
Protein Interaction and Signaling Assays
Co-immunoprecipitation, proximity ligation, and mass spectrometry can identify interacting partners such as Src and PI3K. These methods help elucidate the pump's role in signal transduction beyond ion transport.
Structural and Computational Studies
Cryo-EM and X-ray crystallography provide high-resolution structures of the pump in different conformations. Molecular dynamics simulations and kinetic modeling offer insights into ion translocation and drug binding.
How CRISPR Can Be Used to Study GO:0005890 sodium:potassium-exchanging ATPase complex
Knockout
CRISPR knockout of ATP1A1 in cell lines can be lethal or cause severe growth defects, reflecting its essential role. Conditional knockout in mice allows tissue-specific study of pump function in heart, kidney, or neurons.
Point Mutation
Introducing patient-specific point mutations (e.g., ATP1A2 or ATP1A3) via CRISPR knock-in enables precise modeling of neurological disorders and testing of pharmacological chaperones.
Knock-in
Tagged knock-in of ATP1A1 with fluorescent proteins or epitope tags facilitates live-cell imaging and proteomic analysis of the pump complex.
Overexpression
Overexpression of FXYD proteins or mutant alpha subunits can mimic pathological conditions such as cancer or hypertension, providing a platform for drug screening.
How EDITGENE Supports sodium:potassium-exchanging ATPase complex Research
Researchers studying sodium:potassium-exchanging ATPase complex-related genes often need to determine whether a candidate gene is causally involved in pump function, drug response, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for sodium:potassium-exchanging ATPase complex research.
Frequently Asked Questions About sodium:potassium-exchanging ATPase complex
What is GO:0005890?
GO:0005890 is the Gene Ontology term for the sodium:potassium-exchanging ATPase complex, also known as the sodium pump, a tetrameric ion transporter in the plasma membrane.
What genes are involved in the sodium:potassium-exchanging ATPase complex?
The complex is composed of alpha subunits (ATP1A1, ATP1A2, ATP1A3, ATP1A4) and beta subunits (ATP1B1, ATP1B2, ATP1B3, ATP1B4), with regulatory FXYD proteins.
What is the function of the sodium pump?
It hydrolyzes ATP to transport three Na+ ions out and two K+ ions into the cell, maintaining electrochemical gradients essential for excitability and volume regulation.
How is the sodium:potassium-exchanging ATPase complex structured?
It is a tetramer of two alpha and two beta subunits; the alpha subunit contains the catalytic site and spans the membrane, while the beta subunit is glycosylated and extracellular.
What diseases are associated with sodium pump dysfunction?
Cardiovascular diseases, cancer, neurological disorders such as familial hemiplegic migraine, and renal disorders.
What drugs target the sodium:potassium-exchanging ATPase complex?
Cardiac glycosides such as digoxin and ouabain inhibit the pump and are used for heart failure and arrhythmias.
How can CRISPR be used to study the sodium pump?
CRISPR knockout, knock-in, and point mutations allow researchers to dissect subunit functions, model patient mutations, and screen for drug resistance.
What are FXYD proteins?
FXYD proteins are small regulatory subunits that associate with the sodium pump and modulate its activity in a tissue-specific manner.
Is the sodium pump involved in cancer?
Yes, it is overexpressed in many cancers and contributes to proliferation and survival; its inhibitors show anticancer potential.
What methods are used to study the sodium:potassium-exchanging ATPase complex?
Common methods include CRISPR editing, ion flux assays, electrophysiology, co-immunoprecipitation, cryo-EM, and molecular dynamics simulations.
Conclusion
The sodium:potassium-exchanging ATPase complex (GO:0005890) is a cornerstone of cellular physiology, maintaining ion gradients that underlie excitability, volume regulation, and nutrient transport. Its dysfunction is linked to a broad spectrum of diseases, from heart failure to neurological disorders and cancer. Advances in CRISPR-based models and structural biology continue to unravel its molecular mechanisms and therapeutic potential. EDITGENE's comprehensive services empower researchers to explore this complex with precision and efficiency.
References
- 1. Leng B et al.. 2025. Sodium-Potassium ATPase in cardiovascular diseases: Insights into structure, function, and therapeutic targets.. Biochem Pharmacol 241:117163 PMID: 40659122
- 2. Palmgren M. 2023. Evolution of the sodium pump.. Biochim Biophys Acta Mol Cell Res 1870(7):119511 PMID: 37301269
- 3. Guerra J et al.. 2025. Multistate Kinetic Model of the Sodium-Potassium ATPase.. J Phys Chem B 129(38):9609-9621 PMID: 40934481
- 4. Greeff K et al.. 1984. Cardiac glycosides and sodium/potassium-ATPase.. Basic Res Cardiol 79 Suppl:16-20 PMID: 6331375
- 5. Alevizopoulos K et al.. 2014. Na+/K+ ATPase inhibitors in cancer.. Curr Drug Targets 15(10):988-1000 PMID: 25198786
- 6. Pirkmajer S et al.. 2019. Hormonal regulation of Na(+)-K(+)-ATPase from the evolutionary perspective.. Curr Top Membr 83:315-351 PMID: 31196608
- 7. Cui X et al.. 2017. Protein Interaction and Na/K-ATPase-Mediated Signal Transduction.. Molecules 22(6) PMID: 28613263
- 8. Dimroth P. 1997. Primary sodium ion translocating enzymes.. Biochim Biophys Acta 1318(1-2):11-51 PMID: 9030254
